Table 2.
PAH-albumin adducts and risk of HCC
PAH_Albumin | Cases | Controls | OR(95% CI) | OR*(95% CI) | ||
---|---|---|---|---|---|---|
No. | % | No. | % | |||
Non-detectable | 89 | 51.2 | 409 | 52.7 | 1.0 | 1.0 |
Detectable | 85 | 48.9 | 367 | 47.3 | 1.0(0.6-1.5) | 0.9(0.5-1.4) |
Below mean | 93 | 53.5 | 467 | 60.1 | 1.0 | 1.0 |
Above mean | 81 | 46.6 | 309 | 39.9 | 1.3(0.8-2.0) | 1.1(0.7-1.8) |
Quantile 1‡ | 97 | 55.8 | 501 | 64.6 | 1.0 | 1.0 |
Quantile 2 | 16 | 9.2 | 90 | 11.5 | 1.1(0.6-2.0) | 1.0(0.5-2.0) |
Quantile 3 | 23 | 13.2 | 93 | 12.0 | 1.5(0.8-2.8) | 1.2(0.6-2.4) |
Quantile 4 | 38 | 21.8 | 92 | 11.9 | 2.6†(1.3-5.3)** | 2.0§(1.0-4.2) |
:p value <0.01
: p<0.05
: p for linear trend<0.05
: adjusted for HBsAg status, habitual smoking, and alcohol drinking
: Subjects with detectable adducts were quartiled and those in the lowest quartile combined with those with nondetectable adducts for Quantile 1